FI20080348A0 - A novel pharmaceutical formulation - Google Patents

A novel pharmaceutical formulation

Info

Publication number
FI20080348A0
FI20080348A0 FI20080348A FI20080348A FI20080348A0 FI 20080348 A0 FI20080348 A0 FI 20080348A0 FI 20080348 A FI20080348 A FI 20080348A FI 20080348 A FI20080348 A FI 20080348A FI 20080348 A0 FI20080348 A0 FI 20080348A0
Authority
FI
Finland
Prior art keywords
pharmaceutical formulation
novel pharmaceutical
novel
formulation
pharmaceutical
Prior art date
Application number
FI20080348A
Other languages
Finnish (fi)
Swedish (sv)
Inventor
Giovanni Politi
Erkki Heilakka
Original Assignee
Atacama Labs Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI20080123A external-priority patent/FI20080123A0/en
Publication of FI20080348A0 publication Critical patent/FI20080348A0/en
Priority to FI20080348A priority Critical patent/FI20080348A0/en
Application filed by Atacama Labs Oy filed Critical Atacama Labs Oy
Priority to PCT/FI2009/050111 priority patent/WO2009101258A1/en
Priority to PCT/EP2009/055626 priority patent/WO2009135946A1/en
Priority to EP09742164.8A priority patent/EP2291233B1/en
Priority to CA2723409A priority patent/CA2723409C/en
Priority to US12/580,558 priority patent/US8581134B2/en
Priority to IL209019A priority patent/IL209019A/en
Priority to US12/941,314 priority patent/US8951562B2/en
Priority to US14/582,664 priority patent/US9700513B2/en
Priority to US15/625,696 priority patent/US10265272B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/22Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by pressing in moulds or between rollers
FI20080348A 2006-11-10 2008-05-09 A novel pharmaceutical formulation FI20080348A0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FI20080348A FI20080348A0 (en) 2008-02-15 2008-05-09 A novel pharmaceutical formulation
PCT/FI2009/050111 WO2009101258A1 (en) 2008-02-15 2009-02-13 Novel pharmaceutical formulation
PCT/EP2009/055626 WO2009135946A1 (en) 2008-05-09 2009-05-08 Method and apparatus for dry granulation
EP09742164.8A EP2291233B1 (en) 2008-05-09 2009-05-08 Method for dry granulation
CA2723409A CA2723409C (en) 2008-05-09 2009-05-08 Method and apparatus for dry granulation
US12/580,558 US8581134B2 (en) 2006-11-10 2009-10-16 Method and apparatus for dry granulation
IL209019A IL209019A (en) 2008-05-09 2010-10-31 Method and apparatus for dry granulation
US12/941,314 US8951562B2 (en) 2006-11-10 2010-11-08 Method and apparatus or dry granulation
US14/582,664 US9700513B2 (en) 2006-11-10 2014-12-24 Method and apparatus for dry granulation
US15/625,696 US10265272B2 (en) 2006-11-10 2017-06-16 Method and apparatus for dry granulation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20080123A FI20080123A0 (en) 2008-02-15 2008-02-15 New pharmaceutical formulation
FI20080348A FI20080348A0 (en) 2008-02-15 2008-05-09 A novel pharmaceutical formulation

Publications (1)

Publication Number Publication Date
FI20080348A0 true FI20080348A0 (en) 2008-05-09

Family

ID=39523016

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20080348A FI20080348A0 (en) 2006-11-10 2008-05-09 A novel pharmaceutical formulation

Country Status (2)

Country Link
FI (1) FI20080348A0 (en)
WO (1) WO2009101258A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20080352A0 (en) * 2008-05-09 2008-05-09 Atacama Labs Oy Process for preparing a tablet with high drug content
FI20080353A0 (en) * 2008-05-09 2008-05-09 Atacama Labs Oy Process for preparing a tablet with extra high drug content
FI20080346A0 (en) * 2008-05-09 2008-05-09 Atacama Labs Oy Process for making a tablet containing additives
AU2014200704C1 (en) * 2009-06-22 2018-12-06 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
AU2015264861C1 (en) * 2009-06-22 2017-11-16 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
RU2715680C2 (en) * 2009-06-22 2020-03-03 ВАЙЕТ ЭлЭлСи Sodium ibuprofen tablets and methods for preparing pharmaceutical compositions containing sodium ibuprofen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2551457C2 (en) * 1975-11-15 1982-10-07 Bayer Ag, 5090 Leverkusen Device for separating dust into coarse and fine material in a centrifugal field
ATE195417T1 (en) * 1991-05-13 2000-09-15 Boots Co Plc PHARMACEUTICAL COMPOSITION CONTAINING IBUPROFEN SALT
GB9603699D0 (en) * 1996-02-21 1996-04-17 Boots Co Plc Therapeutic composition
EP1023065A1 (en) * 1997-08-29 2000-08-02 Dsm N.V. Granules free of excipients
CN1527700A (en) * 2001-05-15 2004-09-08 ��������ʲ��������ι�˾ Compaction process for manufacture of sodium phenytoin dosage form
CH693586A8 (en) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Formulation of ibuprofen sodium.

Also Published As

Publication number Publication date
WO2009101258A1 (en) 2009-08-20

Similar Documents

Publication Publication Date Title
CY2018030I2 (en) PHARMACEUTICAL FORM 514
LTPA2018005I1 (en) Pharmaceutical composition
BRPI0920521A2 (en) pharmaceutical combination
SMT201400069B (en) Pharmaceutical formulation
DK3097925T3 (en) PHARMACEUTICAL COMPOSITION
BRPI0820381A2 (en) Pharmaceutical Formulations
BRPI0721651A2 (en) PHARMACEUTICAL COMPOSITION
DK2073795T3 (en) Abuse-safe drug formulation
BRPI1004940A2 (en) pharmaceutical composition
RU2493831C3 (en) PHARMACEUTICAL COMPOSITIONS
BRPI0921654A2 (en) pharmaceutical formulation
BRPI1015939A2 (en) pharmaceutical composition
BRPI1012539A2 (en) pharmaceutical compositions
DK2120884T3 (en) Pharmaceutical composition
DK2285413T3 (en) Pharmaceutical composition
IT1394400B1 (en) PHARMACEUTICAL COMPOSITIONS
BRPI0921313A2 (en) pharmaceutical composition
DK2271618T3 (en) Pharmaceutical compounds
BRPI0820198A2 (en) pharmaceutical compositions
BR112012003149A2 (en) pharmaceutical composition
BR112012001340A2 (en) pharmaceutical compositions
BRPI0912171A2 (en) pharmaceutical composition
DK3202420T3 (en) TRANSDERMAL PHARMACEUTICAL COMPOSITIONS INCLUDING A SERM
FI20080348A0 (en) A novel pharmaceutical formulation
BRPI0912656A2 (en) solid pharmaceutical formulation